Halozyme Therapeutics Inc. (HALO)

$ 72.04
   
  • Change Today:
    $-1.19
  • 52 Week High: $73.94
  • 52 Week Low: $71.04
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 2,967,678
  • Market Cap: $10,468m
  • RiskGrade: 189
  • Beta: 0.02

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,757.98 1,085.05 817.00¢ 8.8 0.4 +25% n/a 0.0%
31-Dec-27 1,981.64 1,316.59 966.25¢ 7.5 0.4 +18% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 72.04
Change Today $ -1.19
% Change -1.63 %
52 Week High $73.94
52 Week Low $71.04
Volume 2,967,678
Shares Issued 145.30m
Market Cap $10,468m
Beta 0.02
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 19-Feb-2026

Time Volume / Share Price
15:59 272 @ $72.05
15:59 100 @ $71.99
15:59 100 @ $72.00
15:59 105 @ $72.00
15:59 400 @ $72.00

Top of Page